Publikationen, an denen er mitarbeitet JOSE LUIS LOBO BERISTAIN (118)

2023

  1. Acute venous thromboembolism in patients with brain cancer: clinical course

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 6

  2. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7

  3. Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study

    Thrombosis Research, Vol. 228, pp. 1-9

  4. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

    British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981

  5. Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings

    Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 1, pp. 34-46

  6. Respiratory Comorbidity and Pulmonary Embolism

    Archivos de Bronconeumologia

  7. The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry

    Thrombosis Research

  8. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

    Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823

2022

  1. Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial

    Thrombosis Journal, Vol. 20, Núm. 1

  2. Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism

    Cancers, Vol. 14, Núm. 17

  3. Effect of Prognostic Guided Management of Patients With Acute Pulmonary Embolism According to the European Society of Cardiology Risk Stratification Model

    Frontiers in Cardiovascular Medicine, Vol. 9

  4. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

    Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4

  5. Erratum: TEMPORARY REMOVAL: PO-55: Effectiveness and safety of enoxaparin in the extended treatment of venous thromboembolism in active cancer patients with renal impairment: results from the RIETECAT-RI cohort study (Thrombosis research PII: S0049-3848(22)00245-6)

    Thrombosis research

  6. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 725-734

  7. Major bleeding in patients with pulmonary embolism presenting with syncope

    European journal of clinical investigation, Vol. 52, Núm. 7, pp. e13774

  8. Multidisciplinary Consensus for the Management of Pulmonary Thromboembolism

    Archivos de Bronconeumologia

  9. Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry

    Frontiers in Medicine, Vol. 9

  10. Statin use and 30-day mortality in patients with acute symptomatic pulmonary embolism

    Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 8, pp. 1839-1851

  11. The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: Findings from the RIETE registry

    Thrombosis Research

2021

  1. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989